EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Focused ultrasound as a therapeutic adjunct in pancreatic cancer: from thermal and mechanical effects to immune modulation

Jae Young Lee, Cyril Lafon, Petros Mouratidis, Timothy Bullock, Joan Vidal-Jove, Jessica Gannon, Eli Vlaisavljevich, Holger Grüll, Tim Meakem, Chrit Moonen

Ultrasonography · 01.05.2026 · 45 (3) · 195-204

DOI: 10.14366/usg.25199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ultrasonography, erschienen am 01.05.2026. Verfasst von Jae Young Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer remains highly lethal, with only limited improvements achieved with surgery, chemotherapy, radiotherapy, or immunotherapy. Focused ultrasound (FUS) offers complementary, noninvasive therapeutic modalities—including thermal ablation, non-ablative mechanical stimulation, and histotripsy—that can debulk tumors, palliate pain, enhance drug delivery through modulation of the dense stromal environment, and stimulate antitumor immunity. Extracorporeal high-intensity focused ultrasound is clinically feasible, while endoscopic and intraoperative approaches aim to overcome anatomical constraints. Preclinical studies demonstrate cavitation-mediated increases in tissue permeability and immune activation, and early clinical trials combining FUS with chemotherapy have reported encouraging signals in response rates and survival outcomes. Ongoing investigations are evaluating synergistic effects with immunotherapies and targeted drug delivery strategies. Key challenges—including the deep anatomical location of the pancreas, its fibrotic microenvironment, and the low immunogenicity of pancreatic tumors—necessitate the standardization of treatment parameters and improvements in image guidance. Overall, FUS represents a promising adjunct within multidisciplinary pancreatic cancer care.

Schlagwörter

Stichwörter der Autor:innen

Drug deliveryFocused ultrasoundHIFUHistotripsyImmunotherapyPancreatic cancer

Autor:innen und Institutionen

  • Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Institute of Radiation Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • LabTAU, INSERM, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France.
  • Institute of Cancer Research, London, UK.
  • University of Virginia, Charlottesville, VA, USA.
  • Comprehensive Tumor Center Barcelona, Barcelona, Spain.

Zitieren

APA

Lee, J. Y., Lafon, C., Mouratidis, P., Bullock, T., Vidal-Jove, J., Gannon, J., Vlaisavljevich, E., Grüll, H., Meakem, T., & Moonen, C. (2026). Focused ultrasound as a therapeutic adjunct in pancreatic cancer: from thermal and mechanical effects to immune modulation. Ultrasonography, 45(3), 195-204. https://doi.org/10.14366/usg.25199

Vancouver

Lee JY, Lafon C, Mouratidis P, Bullock T, Vidal-Jove J, Gannon J, et al. Focused ultrasound as a therapeutic adjunct in pancreatic cancer: from thermal and mechanical effects to immune modulation. Ultrasonography. 2026;45(3):195-204. doi:10.14366/usg.25199

BibTeX
@article{Lee2026,
  author = {Lee, Jae Young and Lafon, Cyril and Mouratidis, Petros and Bullock, Timothy and Vidal-Jove, Joan and Gannon, Jessica and Vlaisavljevich, Eli and Grüll, Holger and Meakem, Tim and Moonen, Chrit},
  title = {Focused ultrasound as a therapeutic adjunct in pancreatic cancer: from thermal and mechanical effects to immune modulation},
  journal = {Ultrasonography},
  year = {2026},
  volume = {45},
  number = {3},
  pages = {195--204},
  doi = {10.14366/usg.25199}
}
Kostenlos starten →